Neogenomics (NEO) Total Debt (2010 - 2020)

Neogenomics (NEO) has 11 years of Total Debt data on file, last reported at $95.6 million in Q1 2020.

• Quarterly Total Debt rose 1.85% year-over-year to $95.6 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $95.6 million (up 1.85% YoY) and the FY2019 annual result came in at $96.8 million, up 1.12% from the prior year.
• Total Debt declined to $95.6 million in Q1 2020, from $96.8 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $99.3 million in Q3 2019 to a low of $52.8 million in Q3 2016.
• A 5-year average of $80.7 million and a median of $78.2 million in 2017 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2017 — Total Debt surged 40.36% — and 2018, when it declined 11.22%.
• Tracing NEO's Total Debt over 5 years: stood at $73.9 million in 2016, then slipped by 4.78% to $70.4 million in 2017, then jumped by 36.08% to $95.8 million in 2018, then increased by 1.12% to $96.8 million in 2019, then retreated by 1.26% to $95.6 million in 2020.
• The last three Total Debt figures came in at $95.6 million (Q1 2020), $96.8 million (Q4 2019), and $99.3 million (Q3 2019), per Business Quant data.